Officer sold
~$2.41MReported value · 10K sh @ $234.66
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1
AbbVie's GC AND SECRETARY sold $2.41M of AbbVie shares. Nobody planned it ahead of time.
Loading…
Reporting person on SEC Form 4
Perry C Siatis
EVP, GC AND SECRETARY
Disclosures on record
16
Companies involved
1
Disclosure history
Officer sold
~$1.35MReported value · 5,777 sh @ $233.51
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1
AbbVie's GC AND SECRETARY sold $1.35M of AbbVie shares. Nobody planned it ahead of time.
Officer sold
~$612KReported value · 2,600 sh @ $235.26
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1
AbbVie's GC AND SECRETARY sold $612K of AbbVie shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.
Officer sold
~$5.15MReported value · 22K sh @ $230.00
Stock since the trade +14.6% · S&P 500 +10.2% · to Oct 1
AbbVie's GC AND SECRETARY sold $5.15M of AbbVie shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.